Achiko has launched a pilot programme of its rapid Covid-19 diagnostic test AptameX in combination with digital health passporting app Teman Sehat in Indonesia. AptameX uses a DNA aptamer-based technology, which the company says improves on the speed of lateral flow tests (LFTs) while matching them in sensitivity. Those that test positive are alerted promptly through the Teman Sehat app and asked to follow local guidelines on isolation and quarantine. The pilot will be held at three sites and will assess unit economics and help train staff and demonstrate the service as a precursor to sales. The move comes nearly two months after Indonesia granted product and registration approval for AptameX.
The US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for PerkinElmer’s PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. The test can identify and distinguish SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV). Qualified laboratories can immediately start using PKamp assay for simultaneous and qualitative detection of the diseases from nasopharyngeal swabs, anterior nasal swabs and mid-turbinate swabs.
Go deeper with GlobalData
Total Testing Solutions (TTS) is providing quick turnaround antigen and PCR testing for Covid-19 free of charge in Los Angeles, US. The free rapid PCR testing is available at the TTS Century City location, while rapid antigen tests can be procured from multiple TTS sites throughout the Los Angeles area. Insured and uninsured patients can use the service, with the billing directed either through their insurance or the CARES initiative.
